Application of CRISPR Cas Systems for Biosensing

Chung Chiun Liu,Yifan Dai

DOI: https://doi.org/10.3390/bios13070672

2023-06-23

Biosensors

Abstract:The essential properties of a biosensor are its sensitivity and selectivity to detect, monitor and quantify the biomarker(s) for the interests of medicine [...]

chemistry, analytical,nanoscience & nanotechnology,instruments & instrumentation

What problem does this paper attempt to address?

CRISPR-Cas systems: From gene scissors to programmable biosensors

Yuxin Zhang,Yunping Wu,Yanfang Wu,Yangyang Chang,Meng Liu

DOI: https://doi.org/10.1016/j.trac.2021.116210

IF: 14.908

2021-04-01

TrAC Trends in Analytical Chemistry

Abstract:<p>The increasing needs for developing biosensors for various applications in infectious disease diagnosis, environmental monitoring, and food safety put forth challenges on sensor performances such as sensitivity, selectivity, assay time, and operation cost. The CRISPR-Cas systems, regarded as molecular scissors, present an extremely high accuracy toward cleaving the targeted DNA and RNA. The presence of a target triggers the activation of CRISPR-Cas system to cleave the specific nucleic acid sequence and generate a signal. Recent studies have demonstrated the establishment of various facile and versatile CRISPR-Cas-based biosensing platforms. In this review, we will briefly introduce the general characteristics and mechanisms of the class II CRISPR-Cas systems, and highlight the biosensing strategies for a wide variety nucleic acid and non-nucleic acid analytes.</p>

chemistry, analytical
CRISPR/Cas‐Powered Biosensing

Mengying Deng,Fengqin Li,Xiaolei Zuo,Min Li

DOI: https://doi.org/10.1002/anse.202200052

2022-08-29

Abstract:CRISPR/Cas system is to be a powerful tool to construct the nucleic acid diagnostic platform. Specific recognition and cleavage of CRISPR/Cas systems enable selective recognition of analytes and physicochemical signal translation of biorecognition events. Given the diversity of Cas effectors, we outline various types of Cas effectors and their associated single‐guide RNA (sgRNA), protospacer adjacent motif (PAM) sequence, or protospacer flanking sequence (PFS), as well as the characteristics of the CRISPR/Cas complex in nucleic acid detection. In light of this, we discuss the coupling of CRISPR/Cas systems to various biosensing strategies (e.g., amplification strategy, electronic methods, or optical methods) and point‐of‐care testing (POCT) (e.g., paper‐based lateral flow assays, field‐effect transistor, microfluidics devices, and solid‐state nanopore sensors) that could enable the specificity and sensitivity of the diagnostic platform for biosensing applications. Additionally, we also discuss the new frontiers and the challenges to be addressed in this field.
Versatile Detection with CRISPR/Cas System from Applications to Challenges

Hui Wu,Xiaoyun Chen,Mengyao Zhang,Xiaofu Wang,Yanju Chen,Cheng Qian,Jian Wu,Junfeng Xu

DOI: https://doi.org/10.1016/j.trac.2020.116150

2021-01-01

Abstract:CRISPR/Cas system is now playing an important role in biosensing applications, especially when the trans cleavage activity of several Cas effectors is discovered. Recently, CRISPR/Cas system combining with multiple detection techniques has been developed for various targets detection, which broadens the application scope of CRISPR/Cas system and makes the system more mature. In this review, the characteristics of four commonly used Cas effectors are first analyzed. Detection strategies based on the binding activity and cleavage activity of CRISPR/Cas system are fully discussed. Various targets including nucleic acids, protein, bacteria, metal ions and small molecules can be detected by CRSIPR/Cas system. However, there are still some challenges need to be addressed in the future, like off-target effect, target sequence limitation, multiplex and quantitative detection limitation, etc. As the CRISPR technology continues to develop, the CRSIPR/Cas system with its unique glamour would provide infinite possibilities for various targets detection in the future.
CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.

Yifan Dai,Yanfang Wu,J. Gooding,Guozhen Liu

DOI: https://doi.org/10.1002/ange.202005398

2020-06-10

Angewandte Chemie

Abstract:Recent advances in CRISPR based biotechnologies have greatly expanded our capabilities to repurpose CRISPR for the development of biomolecular sensors for diagnosing diseases and understanding cellular pathways. The key attribute that allows CRISPR to be widely utilized is the programmable and highly selective mechanism. In this Minireview, we first illustrate the molecular principle of CRISPR functioning process from sensing to actuating. Next, the CRISPR based biosensing strategies for nucleic acids, proteins and small molecules are summarized. We highlight some of recent advances on applications for in vitro detection of biomolecules and in vivo imaging of cellular networks. Finally, the challenges with, and exciting prospects of, CRISPR based biosensing developments are discussed.

Computer Science,Medicine,Biology,Engineering
Application Research Progress in Biosensing and Bioimaging Based on CRISPR-Cas System

Zi-Xuan Guo,Zhi-Qing Yang,Yi Wan,Jing-Hong Li

DOI: https://doi.org/10.19756/j.issn.0253-3820.231041

IF: 1.193

2023-01-01

Chinese Journal of Analytical Chemistry

Abstract:Clustered interspaced short palindromic repeat (CRISPR)-CRISPR associated (Cas) system has a unique ability to cleave target nucleic acids and non-specific single-stranded nucleic acids, and has become a vital tool for gene editing and gene diagnosis in recent years. Because of its high sensitivity, high specificity and the ability to recognize single nucleotide variation, CRISPR-Cas system has been widely used in novel nucleic acid detection biosensors. First of all, the composition and classification of the CRISPR-Cas system were introduced and the development and application process of the CRISPR-Cas system were summarized in this review. On this basis, the mechanism and construction process of biosensors based on different types of CRISPR-CAS systems were introduced, and the recent research progress of biosensors based on CRISPR-Cas system were summarized, including the applications in nucleic acid detection, protein detection and metal ion detection, as well as the applications of CRISPR-CAS systems in genotyping, gene mapping, nucleic acid mutation and other biological imaging, which would provide reference for the subsequent research related to CRISPR-Cas system.
Application of CRISPR/Cas Technology in Biological Nano‐Analysis

Pingping Liu,Gerile Aodeng,Lu Ga,Jun Ai

DOI: https://doi.org/10.1002/slct.202303133

2023-12-05

ChemistrySelect

Abstract:Abstract Currently, with the growing global demand for infectious disease diagnostics, environmental testing and food safety, CRISPR‐Cas (Clustered Regularly Interspaced Short Palindromic Repeats‐CRISPR associated proteins) system has unlimited potential as one of the emerging technologies in the field of biotechnology. Recent studies have shown that CRISPR‐Cas system has become a powerful weapon for gene editing, disease treatment, molecular diagnosis and imaging. As important biomarkers, various nucleic acid and non‐nucleic acid targets need to be detected from various samples before the situation deteriorates. In addition, there are still some limitations and challenges in the current biosensor platforms based on the CRISPR‐Cas system. Therefore, summarising the strategies, strengths and weaknesses, and development prospects of the CRISPR‐Cas system in nucleic acid and non‐nucleic acid target identification is beneficial to fully explore the potential development directions of CRISPR‐Cas‐based biosensor systems. This review briefly introduces and summarises the classification, mechanisms and applications of the system (diagnostics when combined with some signal detection means). In addition, some of the current limitations, challenges and future prospects for optimisation of biosensor platforms based on this system are discussed.

chemistry, multidisciplinary
CRISPR/Cas Systems towards Next-Generation Biosensing

Yi Li,Shiyuan Li,Jin Wang,Guozhen Liu

DOI: https://doi.org/10.1016/j.tibtech.2018.12.005

2019-07-01

Trends in Biotechnology

Abstract:Beyond its remarkable genome editing ability, the CRISPR/Cas9 effector has also been utilized in biosensing applications. The recent discovery of the collateral RNA cleavage activity of the Cas13a effector has sparked even greater interest in developing novel biosensing technologies for nucleic acid detection and promised significant advances in CRISPR diagnostics. Now, along with the discovery of Cas12 collateral cleavage activities on single-stranded DNA (ssDNA), several CRISPR/Cas systems have been established for detecting various targets, including bacteria, viruses, cancer mutations, and others. Based on key Cas effectors, we provide a detailed classification of CRISPR/Cas biosensing systems and propose their future utility. As the field continues to mature, CRISPR/Cas systems have the potential to become promising candidates for next-generation diagnostic biosensing platforms.

biotechnology & applied microbiology
[Application of CRISPR/Cas-based Biosensors for Detecting Nucleic Acid of Pathogens].

Tao Liu,Yachen Tian,Cheng Liu,Shuiqin Fang,Youxue Wu,Meijiao Wu,Bin Li,Hao Yang,Qing Liu

DOI: https://doi.org/10.13345/j.cjb.200679

2021-01-01

Abstract:Clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeats -associated protein (CRISPR/Cas) has been developed as a precise, efficient, affordable and sensitive nucleic acid detection tool due to its efficient targeted binding ability and programmability. At present, biosensors based on CRISPR-Cas system have shown excellent performance in the detection of nucleic acid of pathogens, which has attracted widespread attention, and is expected to replace the conventional detection methods. This review summarizes the latest research progress of biosensors based on CRISPR/Cas system for detecting nucleic acid of pathogens.
CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

Ruya Shi,Ling Zhong,Guozhen Liu,Wing Cheung Mak

DOI: https://doi.org/10.1016/j.trac.2024.117796

IF: 14.908

2024-06-04

TrAC Trends in Analytical Chemistry

Abstract:Clustered, regularly interspaced short palindromic repeats (CRISPR) system exhibits considerable potential in life science and bioengineering due to its exceptional sensitivity and specificity in gene editing and biosensing technology. While substantial efforts have been invested over the past decade in developing versatile CRISPR/Cas biosensing methods, the challenges of translating CRISPR/Cas technology into integrated biosensing devices (especially emerging wearables) for point-of-care (POC) applications persist. This review provides a comprehensive summary of the development of CRISPR/Cas biosensing systems, transitioning from complex lab assays to relatively integrated portable devices supported by novel technologies and advanced platforms (such as lateral flow assay, microfluidics, portable electrochemical biochips, etc.). The intrinsic benefits of various biosensing platforms bolster the CRISPR/Cas system's capacity for high-throughput, multiplexed and automation detection. The article aims to serve as a concise resource, inspiring further combinations of CRISPR/Cas technology with advanced biosensing platforms for POC health monitoring, disease diagnosis and personalized medicine.

chemistry, analytical
CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets

Dai, Huili,Li, Fengqin

DOI: https://doi.org/10.1007/s12274-023-5567-4

IF: 9.9

2023-03-21

Nano Research

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems are becoming powerful tools for disease biomarkers detection. Due to the specific recognition, cis -cleavage and nonspecific trans -cleavage capabilities, CRISPR/Cas systems have implemented the detection of nucleic acid targets (DNA and RNA) as well as non-nucleic acid targets (e.g., proteins, exosomes, cells, and small molecules). In this review, we first summarize the principles and characteristics of various CRISPR/Cas systems, including CRISPR/Cas9, Cas12, Cas13 and Cas14 systems. Then, various types of applications of CRISPR/Cas systems used in detecting nucleic and non-nucleic acid targets are introduced emphatically. Finally, the prospects and challenges of their applications in biosensing are discussed.

materials science, multidisciplinary,chemistry, physical,physics, applied,nanoscience & nanotechnology
Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System

Cong Wei,Xueying Lei,Songcheng Yu

DOI: https://doi.org/10.1021/acssynbio.4c00161

IF: 5.249

2024-06-12

ACS Synthetic Biology

Abstract:A growing number of applications require simultaneous detection of multiplexed nucleic acid targets in a single reaction, which enables higher information density in combination with reduced assay time and cost. Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR-Cas system have broad applications for the detection of nucleic acids due to their strong specificity, high sensitivity, and excellent programmability. However, realizing multiplexed detection is still...

biochemical research methods
The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

Yuxuan He,Wei Yan,Likun Long,Liming Dong,Yue Ma,Congcong Li,Yanbo Xie,Na Liu,Zhenjuan Xing,Wei Xia,Feiwu Li

DOI: https://doi.org/10.3390/genes14040850

IF: 4.141

2023-04-01

Genes

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated proteins (Cas) are promising molecular diagnostic tools for rapidly and precisely elucidating the structure and function of genomes due to their high specificity, programmability, and multi-system compatibility in nucleic acid recognition. Multiple parameters limit the ability of a CRISPR/Cas system to detect DNA or RNA. Consequently, it must be used in conjunction with other nucleic acid amplification techniques or signal detection techniques, and the reaction components and reaction conditions should be modified and optimized to maximize the detection performance of the CRISPR/Cas system against various targets. As the field continues to develop, CRISPR/Cas systems have the potential to become an ultra-sensitive, convenient, and accurate biosensing platform for the detection of specific target sequences. The design of a molecular detection platform employing the CRISPR/Cas system is asserted on three primary strategies: (1) Performance optimization of the CRISPR/Cas system; (2) enhancement of the detection signal and its interpretation; and (3) compatibility with multiple reaction systems. This article focuses on the molecular characteristics and application value of the CRISPR/Cas system and reviews recent research progress and development direction from the perspectives of principle, performance, and method development challenges to provide a theoretical foundation for the development and application of the CRISPR/CAS system in molecular detection technology.

genetics & heredity
Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

Shweta Singh,Rinku Thakran,Ankur Kaushal,Reena V Saini,Adesh Saini,Sonal Datta

DOI: https://doi.org/10.1016/j.microc.2024.110421

IF: 5.304

2024-03-01

Microchemical Journal

Abstract:Clustered regularly interspaced short palindromic sequences (CRISPR)-Cas is one of the most promising gene editing systems. Defined by its specificity, sensitivity, and high base resolution for nucleic acid recognition, CRISPR-Cas has emerged as a tool of choice for biosensing. Biosensing via CRISPR-Cas utilizes the trans-cleavage activity of effectors on various nano-platforms so that different targets, such as viral and bacterial infections, genetic mutations, and tumor biomarkers, could be detected. Various sensing methods employed in these sensors include fluorescence, colorimetric, luminescence resonance, and electrochemical readouts. CRISPR-Cas biosensing offers multiple possibilities for multiplex diagnosis of different diseases by detecting many analytes from one specimen. In this review, we have explored recent advances in CRISPR-based biosensors. Due to their high accuracy and versatility, CRISPR-Cas biosensing displays next-generation point-of-care (POC) diagnostics of multiple targets. The combinations of CRISPR-Cas withmicrofluidictechniques powerfully integrate enhanced analytical sensitivity, portability, shortened detection time, more straightforward automation, scale-up, and integration of lab steps in one device (lab-on-a-chip). This review summarizes the potential of CRISPR-Cas-based biosensor technology in the early and precise diagnosis of viral and bacterial diseases and cancer biomarkers, which could further open up avenues for efficient and specific therapeutic regimens.

chemistry, analytical
Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets

DOI: https://doi.org/10.1186/s13765-023-00771-9

2023-02-19

Applied Biological Chemistry

Abstract:CRISPR-Cas systems have been widely used in genome editing and transcriptional regulation. Recently, CRISPR-Cas effectors are adopted for biosensor construction due to its adjustable properties, such as simplicity of design, easy operation, collateral cleavage activity, and high biocompatibility. Aptamers' excellent sensitivity, specificity, in vitro synthesis, base-pairing, labeling, modification, and programmability has made them an attractive molecular recognition element for inclusion in CRISPR-Cas systems. Here, we review current advances in aptamer-based CRISPR-Cas sensors. We briefly discuss aptamers and the knowledge of Cas effector proteins, crRNA, reporter probes, analytes, and applications of target-specific aptamers. Next, we provide fabrication strategies, molecular binding, and detection using fluorescence, electrochemical, colorimetric, nanomaterials, Rayleigh, and Raman scattering. The application of CRISPR-Cas systems in aptamer-based sensing of a wide range of biomarkers (disease and pathogens) and toxic contaminants is growing. This review provides an update and offers novel insights into developing CRISPR-Cas-based sensors using ssDNA aptamers with high efficiency and specificity for point-of-care setting diagnostics.

food science & technology
Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing

Mengdi Bao,Qun Chen,Zhiheng Xu,Erik C. Jensen,Changyue Liu,Jacob T. Waitkus,Xi Yuan,Qian He,Peiwu Qin,Ke Du

DOI: https://doi.org/10.1021/acssensors.1c00530

IF: 8.9

2021-06-18

ACS Sensors

Abstract:Clustered regularly interspaced short palindromic repeats, CRISPR, has recently emerged as a powerful molecular biosensing tool for nucleic acids and other biomarkers due to its unique properties such as collateral cleavage nature, room temperature reaction conditions, and high target-recognition specificity. Numerous platforms have been developed to leverage the CRISPR assay for ultrasensitive biosensing applications. However, to be considered as a new gold standard, several key challenges for CRISPR molecular biosensing must be addressed. In this paper, we briefly review the history of biosensors, followed by the current status of nucleic acid-based detection methods. We then discuss the current challenges pertaining to CRISPR-based nucleic acid detection, followed by the recent breakthroughs addressing these challenges. We focus upon future advancements required to enable rapid, simple, sensitive, specific, multiplexed, amplification-free, and shelf-stable CRISPR-based molecular biosensors.This article has not yet been cited by other publications.

chemistry, multidisciplinary, analytical,nanoscience & nanotechnology
CRISPR molecular detection techniques: Advances from single to multiple detection methods

Zefeng Mao,Huang Lei,Ruipeng Chen,Shuyue Ren,Baolin Liu,Zhixian Gao

DOI: https://doi.org/10.1016/j.trac.2023.117198

2023-07-24

Abstract:The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-related proteins (CRISPR/Cas) are regarded as the next generation of molecular diagnostic systems. Due to its good biocompatibility, unique cutting activity, ease of operation and design, the CRISPR/Cas system plays an important role in biosensing applications, especially the trans -cutting activity of several Cas effectors. In recent years, CRISPR/Cas, as an emerging molecular recognition component and signal transduction module, has been combined with modern analytical techniques for detecting various analytes. This paper briefly introduces the classification and working principle of CRISPR sensor-related enzymes, summarizes the latest research on the detection of various Cas effectors on single (multiple) targets, and analyzes their application examples in practical and portable sensing from the perspective of multiple detection platforms. Finally, the technical bottleneck and application prospects were summarized.

chemistry, analytical
The Signal-Sensing Techniques and Recent Applications of CRISPR-Cas System

Liu Si-Tong,Huang Zhao-He,Luo Mei-Yu,Wang Zhen,Chen Hong-zheng,Zhang Yu-Jie,Pei Xiao-Jing

DOI: https://doi.org/10.3964/j.issn.1000-0593(2024)04-0918-07

2024-01-01

Spectroscopy and spectral analysis

Abstract:The clustered regularly interspaced short palindromic repeats(CRISPR and CRISPR-associated system,CRISPR-Cas system)is an acquired immune system found in most bacteria and archaea,consisting of Cas enzyme and guide RNA(guide RNA,gRNA),which recognizes and shears target DNA or RNA based on the specificity of gRNA sequence.In recent years,thanks to the excellent enzymatic activity of the CRISPR-Cas system,a variety of biosensing technologies(biosensor)have been established,and optical signal sensing strategies are simple,portable,and widely used in scientific research and practical applications.We summarized in detail the basic principles and representative results and applications of various optical sensing strategies based on the CRISPR-Cas system in the last five years.Also,we provide an outlook on the current application prospects and challenges.
Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Kun Chen,Ziyi Shen,Guanzhen Wang,Wei Gu,Shengchao Zhao,Zihan Lin,Wei Liu,Yi Cai,Gohar Mushtaq,Jia Jia,Tingdong Yan,Chunpeng (Craig) Wan

DOI: https://doi.org/10.3389/fbioe.2022.986233

IF: 5.7

2022-09-17

Frontiers in Bioengineering and Biotechnology

Abstract:CRISPR/Cas technology originated from the immune mechanism of archaea and bacteria and was awarded the Nobel Prize in Chemistry in 2020 for its success in gene editing. Molecular diagnostics is highly valued globally for its development as a new generation of diagnostic technology. An increasing number of studies have shown that CRISPR/Cas technology can be integrated with biosensors and bioassays for molecular diagnostics. CRISPR-based detection has attracted much attention as highly specific and sensitive sensors with easily programmable and device-independent capabilities. The nucleic acid-based detection approach is one of the most sensitive and specific diagnostic methods. With further research, it holds promise for detecting other biomarkers such as small molecules and proteins. Therefore, it is worthwhile to explore the prospects of CRISPR technology in biosensing and summarize its application strategies in molecular diagnostics. This review provides a synopsis of CRISPR biosensing strategies and recent advances from nucleic acids to other non-nucleic small molecules or analytes such as proteins and presents the challenges and perspectives of CRISPR biosensors and bioassays.

multidisciplinary sciences
Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Di Huang,Chutian Xu,Chenhang Jiang,Qixing Chen,Zhinan Xu,Xiangming Fang

DOI: https://doi.org/10.1016/j.trac.2024.117856

IF: 14.908

2024-01-01

TrAC Trends in Analytical Chemistry

Abstract:In recent years, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems have emerged as promising tools in point-of-care testing (POCT) for nucleic acids. However, they still suffer from various challenges, including dependency on professional instruments and skilled operators. To address these issues, the integration of portable signal readout methods with CRISPR systems shows great potential in expediting their development and practical deployment in POCT. Consequently, this review provides a concise overview of the structures and characteristics of prevalent Cas nucleases, such as Cas9, Cas12, and Cas13, and summarizes the representative CRISPR-based biosensors employing the mentioned signal readout systems, including fluorescence, electrochemistry, glucose, color, and distance. Finally, we propose current challenges and insights into potential future developments in signal readout methods for CRISPR nucleic acid detection platforms and their prospects for integration into useful detection toolboxes. We hope this review can provide readers with a fresh perspective on the distinctive features and application potential of CRISPR-based biosensors in the context of POCT.
CRISPR-Cas assisted diagnostics: A broad application biosensing approach

Annalisa Masi,Amina Antonacci,Maria Moccia,Valeria Frisulli,Mariarita De Felice,Mariarosaria De Falco,Viviana Scognamiglio

DOI: https://doi.org/10.1016/j.trac.2023.117028

2023-03-19

Abstract:In addition to its remarkable genome editing capability, the CRISPR-Cas system has proven to be very effective in many fields of application, including the biosensing of pathogenic infections, mutagenic defects, or early cancer diagnosis. Thanks to their many advantages in terms of simplicity, efficiency, and reduced time, several CRISPR-Cas systems have been described for the design of sensitive and selective analytical tools, paving the way for the development and further commercialization of next-generation diagnostics. However, CRISPR-Cas-based biosensors still need further research efforts to improve some drawbacks, such as the need for target amplification, low reproducibility, and lack of knowledge of exploited element robustness. This review aims to describe the latest trends in the design of CRISPR-Cas biosensing technologies to better highlight the insights of their advantages and to point out the limitations that still need to be overcome for their future market entry as medical diagnostics.

chemistry, analytical

Application of CRISPR Cas Systems for Biosensing

CRISPR-Cas systems: From gene scissors to programmable biosensors

CRISPR/Cas‐Powered Biosensing

Versatile Detection with CRISPR/Cas System from Applications to Challenges

CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.

Application Research Progress in Biosensing and Bioimaging Based on CRISPR-Cas System

Application of CRISPR/Cas Technology in Biological Nano‐Analysis

CRISPR/Cas Systems towards Next-Generation Biosensing

[Application of CRISPR/Cas-based Biosensors for Detecting Nucleic Acid of Pathogens].

CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets

Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets

Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing

CRISPR molecular detection techniques: Advances from single to multiple detection methods

The Signal-Sensing Techniques and Recent Applications of CRISPR-Cas System

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-Cas assisted diagnostics: A broad application biosensing approach